Erik Ooi Email & Phone Number

Toronto, Ontario, Canada

Toronto, Ontario, Canada

• Performed experience studies related to overall profitability of the Basic Life and Waiver of Premium blocks of business
• Owned the process of allocating LICAT capital to the policy-level for use across the Group Benefits Pricing teams.
• Supported data-driven financial reviews of product initiatives and ad-hoc pricing projects by providing insights and metrics to senior leaders and partners in Underwriting.
• Initiated deep-dive reviews of the Life and Dental predictive models in collaboration with external consultants.
• Attracted new talent to the organization by serving as a representative in Campus Recruiting events, and interviewed candidates for full-time actuarial positions.

Toronto, Ontario, Canada

• Led the development of customized quotations and intellectual capital.
• Managed the team’s timeline to ensure the accurate and timely delivery of group annuities.
• Communicated with pension consultants and plan sponsors to clarify various pricing issues and considerations for payout annuity and longevity insurance purchases.
• Stayed abreast of market longevity trends and regulatory changes that may impact existing pricing initiatives.
• Supported the pricing and profitability reviews of existing products in accordance with the product design and pricing approval process.
• Collaborated with internal stakeholders to support the development and design of new products.

• Assisted in the completion of Plan VNB by assessing VNB documents submitted by various business groups for completeness
• Oversaw the model governance process by ensuring that models owned by GRS are compliant with MEUC guidelines
• Completed the annual GRS compliance documents for Fraud Risk Assessment and AML/ATF

Waterloo, Ontario

• Supported the implementation of new products in AXIS by validating and reconciling projections.
• Ran Quarter-End processes to quantify reserve changes and new business gains.
• Analyzed and implemented assumption changes in valuation models to reflect current experience.
• Participated in the dividend scale change process to increase competitiveness within the industry.
• Reconciled critical illness and death benefit amounts to produce actual-to-expected ratios.
• Constructed LICAT overrides in valuation models to quantify the impact of various shocks.